Compare Medpace Holdings Inc (MEDP) vs Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? Medpace Holdings Inc trades at $534.03 (market cap $15.08B), while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $29.73. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Roundhill Innov-100 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | QDTE | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $620.59 | $36.60 |
52-Week Low | $308.88 | $26.85 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
QDTE (Roundhill Innovation-100 0DTE Covered Call Strategy ETF) trades at $29.22, up 0.31% on the day, while technical indicators signal a bearish trend with strong sell signals from moving averages. The ETF generates weekly dividends, with recent payouts ranging from $0.12 to $0.28, but financial ratios like P/E and P/S are unavailable. News highlights focus on its high distribution yield amid declining volatility, with comparisons to peers like XDTE.
Outlook remains cautious due to bearish technicals and fee concerns, though the weekly income strategy appeals to yield-seeking investors. Risks include sensitivity to market volatility and competitive pressure from other income ETFs. Investors should weigh the high yield against potential capital erosion from covered call strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Roundhill Innov-100 0DTE Covered Call Strat ETF
QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →
